Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Crucell N.V. (CRXL) -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (533)	1/28/2009 8:45:24 AM
From: kenhott	Read Replies (2) \| Respond to of 560

OT- <reply>not about CRXL <reply> My opinion is that even thought the drug is active they will more than likely miss the primary, but certainly will hit some of the secondaries including the key PFS because the drug is active and the secondaries are pooled but the primary is not, etc. I have been struggling to figure out how to put together a trade because all the options are $$$$ which makes it hard to run the gap between risk/return. Just going short would be nuts. It wouldn't be a major shock if they hit the primary but that is not what I'd expect. Taking a flyer on the long side is not a stupid play but hard to find anything cheap.